Critics of America’s current drug payment system say middlemen are jacking up prices and question why AARP, which is tied to a middleman organization, opposes a Trump administration proposal that could help seniors.
Watch our interview with Dr. David Pate (president and chief executive officer of St. Luke’s Health System) and read his post below to gain insight into the new venture in healthcare (still without a name) that is being formed by Bezos, Dimon, and Buffett. This interview is being brought to you by Paychex, where our HExN […]
By Dr. David C. Pate It’s been a full and eventful year on all levels, local to global and everything in between, in health care and in so many other areas of our economy and business activity. We’ve seen considerable change in government, in payer structures, on the regulatory front … I am hard-pressed to […]
Jack Whelan is a 8 yr survivor of a rare, incurable blood cancer moving from a career IT Research Analyst to Research Advocate. Using business communications and research skills from his career as a Wall Street Research Analyst in Information Technology (IT) and career Sales VP in IT, he now helps bridge the communications gap […]
As a member of the HExN community, your healthcare organization can benefit from an exclusive offer from TSI, formerly Transworld Systems, the industry leader in healthcare collections. TSI can help you greatly improve cashflow through their array of solutions that enable you to collect money faster while maintaining a positive relationship with your patients. […]
By Dr. David C. Pate, CEO of St. Luke’s Health System On July 11, President Obama took the unusual step of writing about the Affordable Care Act for the Journal of the American Medical Association, outlining “progress to date and next steps.” Nearing the end of his second term in office, President Obama reflected on […]
What is value in today’s oncology market? This is a question dividing pharma, payers, providers, and patients. At a time when drug reimbursement is a continuously changing landscape, it is more important than ever to align all stakeholders on a common definition. Back for a 7th year, eyeforpharma Oncology Leadership Summit (June 16-17) brings together […]
The recent webinar “Demonstrating Value in Price” turned out to be one of the hottest debates between key oncology stakeholders in 2016! Throughout the discussion your industry peers asked a plethora of vital questions on pricing & value frameworks… In response, eyeforpharma has developed a paper compiling industry research, top insights from the webinar, and […]
With the Sustainable Growth Rate (SGR) formula coming to an end, and Medicare Access & CHIP Reauthorization Act of 2015 (MACRA) on the horizon, it is vital to be up to speed on the latest alternative payment models! This newly developed whitepaper covers it all – “Emerging Payment Models: Navigate the current state of financial uncertainty […]
Health care IT security has been lackluster of late, to say the least, as countless breaches of patient data have taken place in a relatively short period of time with no signs of a changing tide rolling in soon. This is one of the many reasons why regulators and law enforcement officials have started to […]
by Jacquelyn Burton, BSHA, MBA/HRM, NCMA Here’s my take on how federal, state, local government and employers can do their part to make health a little more equitable in the United States. Existing intervention in Canada to improve health inequities Health inequities begin in the womb due to genetics, physical, and environmental factors that can […]
An in-depth study by Pew Waterhouse suggests that consumers, providers, and healthcare executives are ready to utilize mHealth (mobile health via smartphones, tablets, desktops, and laptops) in healthcare access and delivery. According to the study, which involved interviewing over 25 executives, 1,500 clinicians, and 1,000 patients: 1. Over 2/3 of consumers would use mHealth if given the opportunity, while only […]
“Money and Medicine,” a documentary on PBS, investigates some of the most notorious drivers of U.S. health care costs. Ray Suarez speaks with Roger Weisberg, the producer and director of the film, about some of the reasons these costs are driving the nation toward financial crisis — while still producing relatively mediocre medical results.
by David C. Pate, M.D., J.D., is president and CEO of St. Luke’s Health System Superficially, the problem is clear. U.S. healthcare costs are too high, rising too rapidly, and higher than those of other industrialized nations. And while it may be appealing to blithely conclude that this is the fault of overpaid doctors, […]